An observational study in Acquired Brain Injury and Cerebral Palsy, sponsored by IRCCS Eugenio Medea. Recruiting at 1 site in Italy. Open to participants aged 5 Years to 20 Years. Per ClinicalTrials.gov, last updated 2024-03-19.
Sponsored by IRCCS Eugenio Medea · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Brain Injuries by IRCCS Eugenio Medea — 4 open to participants now, 4 under way, none of them phase 3. Brain Injuries · IRCCS Eugenio Medea.
Among the 11 studies in Brain Injuries by IRCCS Eugenio Medea, this one is the only one that started in 2021, is one of 6 observational ones, and was the 9th registered.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
Browse Brain Injuries studies →4 of the 11 studies in Brain Injuries by IRCCS Eugenio Medea are open now, in 1 country. Recruiting first, the newest first:
IRCCS Eugenio Medea · Sites in Italy
Ages 6–14
IRCCS Eugenio Medea · Sites in Italy
Ages 2 mo–25 yrs
IRCCS Eugenio Medea · Sites in Italy
Ages 6–11
By country, each count listing its studies:
Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.
This study: 5 Years to 20 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 1 started in 2021.
This study's planned enrollment of 100 is close to the median of 100 across 302 observational studies indexed under Brain Injuries.
Median enrollment 30 across the 5 interventional studies, 74 across the 6 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IRCCS Eugenio Medea is the lead sponsor of 109 studies on the registry; 52 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Brain Injuries by IRCCS Eugenio Medea, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Gait pattern difficulties, balance and coordination deficits often characterize patients with congenital and acquired neuromotor disorders and have a significant impact on the quality of life of these subjects. There are various treatments used and in recent years, the advent of advanced technologies in rehabilitation and, in particular, devices based on virtual reality, has opened up new possibilities in rehabilitation. Virtual reality is a promising strategy that incorporates many principles crucial to motor learning, such as high-intensity, repetitive, goal-oriented tasks, enhanced synchronized sensory signals, and active participation. The virtual environment is also suitable for personalized treatment based on the needs of the individual patient.
The GRAIL (Gait Real-time Analysis Interactive Lab) is a device that integrates immersive virtual reality with an instrumented treadmill and a motion capture system, which can be used with both rehabilitation and evaluation goals. To date, there are still few studies of this device in the pediatric field.
The objective of the study is to verify the performance in clinical practice of the immersive virtual reality platform GRAIL and determine any secondary effects by evaluating whether they entail acceptable risks compared to the expected performances following the protocol defined at the IRCCS Medea by Bosisio Parini, in children and adolescents with congenital and acquired neuromotor pathology.
Patients suffering from acquired and congenital brain injuries undergo a combined rehabilitation treatment consisting of 20 sessions with GRAIL and 20 physiotherapy sessions in four weeks. The same subjects undergo evaluations before and at the end of the treatment
The study is prospective and involves the verification of performance through clinical and instrumental evaluations in the population of subjects treated with the GRAIL device at the IRCCS Medea-Bosisio Parini.
Children aged 5 to 20 with either cerebral palsy or acquied brain injury, who can follow verbal orders and are not disabled regarding senses or intellect
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients in this group receive Physical Rehabilitation and GRAIL treatment
Procedure: Physical Rehabilitation · Device: Gait Real-time Analysis Interactive Lab
Patients in this group receive Physical Rehabilitation not GRAIL treatment
Procedure: Physical Rehabilitation
5 sessions of physical rehabilitation per week. Each session lasting 45 minutes. Overall 20 sessions = 4 weeks.
5 sessions of GRAIL assisted rehabilitation per week. Each session lasting 45 minutes. Overall 20 sessions = 4 weeks.
6 minute walking test
Distance walked over 6 minutes, in meters
Time frame: Before and after 4 weeks of treatment
Gross Motor Function Measure -total score
Total score on the Gross Motor Function Measure. Greater scores indicate better performance
Time frame: Before and after 4 weeks of treatment
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2021 (actual). Primary completion is estimated for Apr 2026, 60 months after the start.
Of 144 non-industry observational studies under Brain Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 73. This study's planned 60 months is above that.
Counting every sponsor, half of 149 studies reached it within 31 months; a quarter within 16 and three quarters within 73.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.